Healx has established itself at the leading edge of this third generation of drug discovery by creating a suite of AI-driven methods that promise to increase the speed, scale and chance of success ...
Cambridge, UK-based healthtech startup Healx has just raised a $56 million Series B led by one of Europe's biggest investors to use artificial intelligence to treat the world's rarest diseases.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback